DALLAS (AP) — Susan G. Komen for a Cure announced Monday that a medicine with a prolonged career in health process and investigate will turn a breast cancer charity’s new boss and CEO.

Judith A. Salerno will reinstate Nancy Brinker as CEO of a Dallas-based organization. Brinker, whose guarantee to her failing sister begat a fundraising powerhouse that has invested hundreds of millions of dollars in cancer research, announced final summer she would step down following an assault of critique over Komen’s preference — fast topsy-turvy — to stop giving grants to Planned Parenthood for breast cancer screenings.

Salerno, 61, is executive executive and arch handling officer of a Institute of Medicine of a National Academy of Sciences, a prestigious eccentric organisation that advises a supervision and private zone about health and science.

“Komen’s joining has helped large numbers of low-income and medically underserved women and group get caring they competence differently have left without, and Komen’s investigate module is one of a many rarely reputable in a nation,” Salerno pronounced in a statement.

The appointment of Salerno, with her low medical background, comes after a embattled Komen substructure saw several executives leave and numbers tumble during their fundraising Races for a Cure opposite a nation in a months after a Planned Parenthood controversy. Earlier this month, Komen announced it was canceling half of a three-day gift walks due to a dump in appearance levels.

When asked about Salerno’s views on Planned Parenthood or a appropriation controversy, Komen mouthpiece Andrea Rader pronounced a gift was focusing on relocating forward.

“That’s an emanate that was staid a prolonged time ago,” Rader said, also describing Salerno as a good fit due to her knowledge in a operation of areas, from open process to village health.

Leaders of Komen affiliates met Monday’s proclamation with enthusiasm.

“It looks to me like they did a very, really consummate pursuit and found an ideal candidate,” pronounced Dana Curish, executive executive for a group’s executive Indiana associate in Indianapolis. “From her credentials and experience, she sounds like she’ll be a ideal chairman to lead us going forward.”

Curish pronounced that a CEO can accomplish a lot only by revelation Komen’s story.

“What we’re doing is separate to a Planned Parenthood controversies though those controversies are impacting a dollars that we have accessible to comment investigate and to comment services for low-income individuals,” Curish said. “We only need to continue to tell that story as best we can.

“If a dollars dry up, so will a breakthroughs,” she said.

Brinker founded a gift in respect of her sister, who died of breast cancer in 1980. Its signature tone of pinkish has turn synonymous with breast cancer awareness. The 67-year-old announced in Aug that she would pierce from a CEO role, that she’d hold given 2009, into a new one focused on fundraising and vital planning.

News pennyless in late Jan 2012 about a charity’s preference to hindrance grants to Planned Parenthood, causing a swell of questions and calls for a reversal. The preference was topsy-turvy within days, though finished adult angering Komen supporters on both sides of a termination debate.

Karen Handel, who was hired by Komen as clamp boss for open process in Apr 2011, had been given a charge of reckoning out how to disentangle a gift from Planned Parenthood. She quiescent about a week after a preference became open and after wrote a peppery comment of a part in a book patrician “Planned Bullyhood.”

Komen also recently canceled a 3-day races — in that participants lift during slightest $2,300 to travel 60 miles over 3 days — in 7 of a 14 cities for subsequent year.

Planned Parenthood orator Eric Ferrero pronounced in a matter Monday it wished Salerno good in her new role, adding, “we’re unapproachable of the continued partnerships with Komen and others to safeguard that all women, regardless of income, have entrance to information and high-quality health caring to prevent, detect and provide breast cancer.”

Salerno is board-certified in inner medicine, warranted her M.D. from Harvard Medical School in 1985 and a master of scholarship in health process from Harvard School of Public Health in 1976.

___

Associated Press author Nomaan Merchant contributed to this report.

credit

NEW YORK, Jun 17, 2013 /PRNewswire/ — Reportlinker.com announces that a new marketplace investigate news is accessible in a catalogue:

MediPoint: Breast Cancer Imaging – APAC Analysis and Market Forecasts

http://www.reportlinker.com/p01360841/MediPoint-Breast-Cancer-Imaging—APAC-Analysis-and-Market-Forecasts.html#utm_source=prnewswireutm_medium=prutm_campaign=Medical_Imaging

MediPoint: Breast Cancer Imaging – APAC Analysis and Market Forecasts

Summary

Breast cancer is a many common form of cancer in women in both a grown and building world, though is a singular illness in men. The tellurian occurrence of breast cancer is augmenting due to an augmenting lifespan and augmenting adoption of western lifestyle risk factors. Early diagnosis of breast cancer is a substructure for augmenting presence rates and evidence imaging is a many widely used technique to grasp early detection, creation evidence imaging a cornerstone of breast cancer control.

The APAC breast cancer imaging marketplace is a mature attention with formidable dynamics and it is essential to inspect a marketplace opportunities and barriers that are specific to this region. This news provides an in-depth examination of a elaborating technologies and a regulatory landscape of a breast cancer screening marketplace in APAC.

Scope

- An overview of breast cancer, that includes epidemiology, etiology, symptoms, diagnosis, pathology and diagnosis guidelines.
- Annualized APAC Breast cancer imaging marketplace income and destiny forecasts from 2009 to 2011, foresee for 7 years to 2018.
- Investigation of stream and destiny marketplace foe for Breast cancer imaging
- Insightful examination of a pivotal attention drivers, restraints and hurdles as good as likely impact of pivotal events.
- Competitor comment including device capitulation research and device sales forecasts.
- Marketed and tube product profiles covering efficiency, safety, clinical investigate details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within a marketplace and opportunities for destiny players.
- Technology trends research to consider strength of pipeline.
- An overview of all inclination in expansion including clinical investigate details, pattern and element preference considerations, efficiency reports, and device capitulation timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of pivotal marketplace players.
- Strategic comment of a Breast cancer imaging zone by marketplace impact analysis, destiny marketplace unfolding and association analysis.
- Direct quotes from Key Opinion Leaders (KOL) as good as radiologists

Reasons to buy

- Understand a trends moulding and pushing APAC Breast cancer imaging Market.
- Realize device preferences of physicians who have achieved a tests already.
- Access marketplace sizing, forecasts and quantified expansion opportunities in APAC Breast cancer imaging Market by 2018.
- Quantify claimant studious populations to improved pattern product pricing launch plans.
- Drive revenues, delineate effective sales and selling strategies and benefit in-depth bargain of a rival landscape.
- Perform benchmarking research of expansion opportunities opposite now marketed products.
- Assess competitiveness of products in marketplace by bargain a strengths and weaknesses of stream competition.
- Take a extensive demeanour during a market’s device tube and brand promising, paradigm-shifting products.
- Create an effective counter-strategy to benefit a rival advantage opposite those now in a market.
- Organize your sales and selling efforts by identifying a marketplace categories and segments that benefaction a best opportunities for growth.
- What’s a subsequent large thing in APAC Breast cancer imaging marketplace landscape? Identify, know and capitalize.

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 13
1.2 List of Figures 18
2 Introduction 21
2.1 Catalyst 21
3 Disease Overview 22
3.1 Anatomy Physiology of a Breast 22
3.2 Pathophysiology of Breast Cancer 23
3.3 Detection of Breast Cancer 23
3.4 Types of Breast Cancer 24
3.5 Clinical Presentation 26
3.6 Clinical Outcomes 27
3.6.1 Assessment Procedure 27
3.6.2 Screening Guidelines 30
3.7 Epidemiology of Breast Cancer 32
3.8 Economic Impact of Breast Cancer Imaging 35
4 Imaging Techniques 36
4.1 Mammography 36
4.1.1 Overview 36
4.1.2 Types of Mammography 38
4.2 Non-Mammographic Techniques 43
4.2.1 Breast Ultrasound Imaging 43
4.2.2 Breast Magnetic Resonance Imaging 44
4.3 Comparison of Mammography, Ultrasound, and MRI 45
4.4 Alternative Breast Imaging Techniques 46
4.4.1 Nuclear Imaging Techniques 47
4.4.2 Computed Tomography 48
4.4.3 Optical Breast Imaging 49
4.4.4 Electric Impedance-Based Techniques 49
4.4.5 Thermography 50
4.4.6 Elastography 50
4.4.7 Ductogram 50
5 Competitive Assessment 51
5.1 Overview 51
5.2 Film Screen Mammography 52
5.2.1 Performa (GE Healthcare) 52
5.2.2 Alpha RT/Alpha ST (GE Healthcare) 55
5.2.3 MAMMOMAT 1000 (Siemens Healthcare) 58
5.2.4 MAMMOMAT 3000 Nova (Siemens Healthcare) 60
5.2.5 M-IV/M-IV Platinum (Hologic) 62
5.2.6 MammoDiagnost (Philips Healthcare) 64
5.2.7 Planmed Nuance Classic (Planmed) 66
5.2.8 Planmed Sophie Classic (Planmed) 68
5.2.9 Analog Giotto Image (Internazionale Medico Scientifica) 70
5.2.10 HAWK-2M (Hologic) 72
5.2.11 MGU-1000A (Toshiba Medical Systems) 74
5.3 CR Mammography 76
5.3.1 Fuji Computed Radiography Mammography Suite (FCRMS) (Fujifilm Medical Systems) 76
5.3.2 KODAK DirectView (Carestream Health) 78
5.3.3 Xpress CR System (Konica Minolta) 80
5.3.4 REGIUS PureView (Konica Minolta) 82
5.3.5 Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) (Agfa Healthcare) 84
5.4 Full-Field Digital Mammography 86
5.4.1 Selenia Dimensions (Hologic) 87
5.4.2 Selenia (Hologic) 90
5.4.3 Selenia S (Hologic) 92
5.4.4 Selenia Performance (Hologic) 94
5.4.5 Senographe DS (GE Healthcare) 96
5.4.6 Senographe Essential (GE Healthcare) 98
5.4.7 Senographe Care (GE Healthcare) 100
5.4.8 SenoBright CESM (GE Healthcare) 102
5.4.9 MAMMOMAT Inspiration (Siemens Healthcare) 104
5.4.10 Aspire HD (US)/Amulet (Outside a US) (Fujifilm) 106
5.4.11 MammoDiagnost DR (Philips Healthcare) 108
5.4.12 MicroDose (Philips Healthcare) 110
5.4.13 Giotto Image 3D/3DL (Internazionale Medico Scientifica) 112
5.4.14 Planmed Nuance/Nuance Excel (Planmed) 114
5.4.15 Fairy DR (Allengers Medical Systems) 116
5.4.16 Serenity 118
5.5 3D Mammography 120
5.5.1 Selenia Dimensions 3D System (Hologic) 120
5.5.2 GE Breast Tomosynthesis (GE Healthcare) 122
5.5.3 True 3D Breast Tomosynthesis (Siemens Healthcare) 124
5.5.4 Giotto Tomo (Internazionale Medico Scientifica) 126
5.5.5 FUJIFILM 3Dimensional Mammography (Fujifilm) 128
5.6 Breast Ultrasound Imaging 130
5.6.1 somo.v Automated Breast Ultrasound (ABUS) (GE Healthcare) 130
5.6.2 SonoCine AWBUS (SonoCine) 132
5.6.3 ACUSON S2000 ABVS (Siemens Healthcare) 134
5.6.4 Terason t3200 Ultrasound System Breast Series (Terason Ultrasound) 136
5.7 Breast MRI 138
5.7.1 Aurora 1.5T Dedicated Breast MRI System (Aurora Imaging Technology) 138
5.8 Other Breast Imaging Techniques 140
5.8.1 PEM Flex Solo II (Naviscan) 140
5.8.2 Computerized Tomography Laser Mammography (CTLM) Model 1020 (Imaging Diagnostic Systems) 142
5.8.3 Dilon 6800/Dilon 6800 Acella (Dilon Diagnostics) 144
5.8.4 LumaGEM (Gamma Medica) 146
5.8.5 Discovery NM 750b (GE Healthcare) 148
6 Unmet Needs 150
6.1 Lower Radiation Dose 150
6.2 Increase Patient Comfort 152
6.3 Reduce False-Positives and False-Negatives 154
6.4 Loss of Sensitivity of Mammography in Dense Breasts 156
6.5 Unreliable Mammograms in Surgically-Operated Breasts and Breasts with Implants 159
6.6 Commitment to Training 160
7 Pipeline Products 163
7.1 Breast Cancer Imaging Pipeline Products Overview 163
7.2 MAMMOMAT Inspiration PRIME Edition 164
7.2.1 Overview 164
7.2.2 SWOT Analysis 164
7.3 MicroDose SI 165
7.3.1 Overview 165
7.3.2 SWOT Analysis 165
7.4 Selenia Dimensions 2D Contrast-Enhanced Digital Mammography (CEDM) 166
7.4.1 Overview 166
7.4.2 SWOT Analysis 166
7.5 SenoCase 167
7.5.1 Overview 167
7.5.2 SWOT Analysis 168
7.6 Electrical Mammogram 169
7.6.1 Overview 169
7.6.2 SWOT Analysis 169
8 Industry Overview 170
8.1 Purchasing Cycle 170
8.1.1 Product Life Cycle 170
8.1.2 Cost Effectiveness in Screening Settings 172
8.1.3 Cost-Effectiveness in Diagnostic Settings 172
8.2 Market Access 173
8.2.1 Purchasing Decisions 173
8.2.2 Regulatory Process 174
8.3 Quality Assurance 175
8.3.1 Japan 175
8.3.2 China and India 175
8.4 Adoption of New Technologies 176
8.4.1 Influence of Clinical Trials Results 176
8.4.2 Reimbursement 177
8.4.3 Economic Resources 177
8.4.4 Low Breast Cancer Incidence and Absence of a National Screening Program 177
8.4.5 Competitive Advantage 178
8.5 Current Reimbursement Trends in APAC 179
8.5.1 Japan 179
8.5.2 China 179
8.5.3 India 180
8.6 Trends in Detector Technology for Digital Mammography 180
8.7 Evolving Scatter-Removal Mechanisms 184
8.8 Overdiagnosis 186
8.9 Malpractice Litigations 187
8.10 Mergers and Acquisitions/Key Partnerships 188
8.10.1 GE Healthcare Acquires U-Systems 188
8.10.2 Koninklijke Philips Electronics Acquires MicroDose Mammography from Sectra 188
8.10.3 Hologic Acquires Beijing Healthcome Technology 188
8.10.4 Hologic Acquires Sentinelle Medica 188
8.10.5 Koninklijke Philips Electronics Acquires Shanghai Apex Electronics Technology 189
8.10.6 Fujifilm Medical Systems acquired FUJIFILM-RU 189
8.10.7 Other Key Events 189
9 Current and Future Players 190
9.1 Overview 190
9.2 Trends in Corporate Strategy 191
9.3 Company Profiles 192
9.3.1 GE Healthcare 192
9.3.2 Hologic 194
9.3.3 Siemens 196
9.3.4 Koninklijke Philips Electronics 197
9.3.5 Fujifilm Medical Systems 199
9.3.6 Internazionale Medico Scientifica (IMS) 200
9.3.7 Planmed 201
9.3.8 Konica Minolta Medical Imaging 202
9.3.9 Agfa Healthcare 203
9.3.10 Carestream Health 204
9.3.11 SonoCine 205
9.3.12 Aurora Imaging Technology 206
9.3.13 Imaging Diagnostic Systems 207
9.3.14 Naviscan 208
9.3.15 Dilon Diagnostics 209
9.3.16 Gamma Medica 210
9.3.17 Allengers Medical Systems 211
10 Market Drivers Opportunities 212
10.1 Market Drivers 212
10.1.1 Increase in a Incidence of Breast Cancer 212
10.1.2 Increased Awareness of a Benefits of Screening 212
10.1.3 Increased Breast Cancer Incidence Due to an Aging Population 213
10.1.4 New Technologies to Drive Market Growth 213
10.1.5 Adoption of Digital Mammography Units in APAC 214
10.2 Opportunities 215
10.2.1 Emerging Economies Promise Future Growth 215
10.2.2 Invest in Emerging Technologies 216
10.2.3 Product Improvement 217
10.3 Market Barriers 218
10.3.1 Shortage of Dedicated Mammography Professionals 218
10.3.2 Reduced Hospital Budgets 218
10.3.3 Refurbished Equipment Sales 219
10.3.4 Reimbursement 220
10.3.5 Substitutes 220
11 Country Outlooks Forecasts 221
11.1 Major Markets Overview 221
11.2 Japan 223
11.2.1 Japan Market Analysis 223
11.3 China 224
11.3.1 China Market Analysis 224
11.4 India 226
11.4.1 India Market Analysis 226
12 Appendix 228
12.1 Bibliography 228
12.2 Abbreviations 255
12.3 Report Methodology 260
12.3.1 Overview 260
12.3.2 Coverage 260
12.3.3 Secondary Research 260
12.3.4 Forecast Methodology 261
12.4 Physicians and Specialists Included in this Study 262
12.5 Primary Research 263
12.6 Physician Survey 263
12.7 About a Authors 264
12.7.1 Analysts 264
12.7.2 Global Head of Healthcare 265
12.8 Definitions 266
12.9 About MediPoint 267
12.10 About GlobalData 267
12.11 Contact Us 267
12.12 Disclaimer 267

List of Tables

Table 1: Breast Cancer Types, Including Diagnostic Procedures 25
Table 2: ACR Breast Imaging Reporting and Database System (BI-RADS) 27
Table 3: Selected Breast Cancer Incidence Rates of India and China, 2002 33
Table 4: Comparison of Mammography, Ultrasound, and MRI for Breast Imaging 45
Table 5: Performa Product Profile 53
Table 6: Performa SWOT Analysis 54
Table 7: Alpha RT/Alpha ST Product Profile 56
Table 8: Alpha RT/Alpha ST SWOT Analysis 57
Table 9: MAMMOMAT 1000 Product Profile 58
Table 10: MAMMOMAT 1000 SWOT Analysis 59
Table 11: MAMMOMAT 3000 Nova Product Profile 61
Table 12: MAMMOMAT 3000 Nova SWOT Analysis 61
Table 13: M-IV/M-IV Platinum Product Profile 63
Table 14: M-IV/M-IV Platinum SWOT Analysis 63
Table 15: MammoDiagnost Product Profile 65
Table 16: MammoDiagnost SWOT Analysis 65
Table 17: Planmed Nuance Classic Product Profile 67
Table 18: Planmed Nuance Classic SWOT Analysis 67
Table 19: Planmed Sophie Classic Product Profile 69
Table 20: Planmed Sophie Classic SWOT Analysis 69
Table 21: Analog Giotto Image Product Profile 71
Table 22: Analog Giotto Image SWOT Analysis 71
Table 23: HAWK-2M Product Profile 73
Table 24: HAWK-2M SWOT Analysis 73
Table 25: MGU-1000A Product Profile 75
Table 26: MGU-1000A SWOT Analysis 75
Table 27: Fuji Computed Radiography Mammography Suite (FCRMS) Product Profile 77
Table 28: Fuji Computed Radiography Mammography Suite (FCRMS) SWOT Analysis 77
Table 29: KODAK DirectView CR System Product Profile 79
Table 30: KODAK DirectView CR System SWOT Analysis 79
Table 31: Xpress CR System Product Profile 80
Table 32: Xpress CR System SWOT Analysis 81
Table 33: REGIUS PureView Product Profile 83
Table 34: REGIUS PureView SWOT Analysis 83
Table 35: Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) Product Profile 85
Table 36: Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) SWOT Analysis 85
Table 37: FFDM SWOT Analysis 86
Table 38: Selenia Dimensions Product Profile 88
Table 39: Selenia Dimensions SWOT Analysis 89
Table 40: Selenia Product Profile 91
Table 41: Selenia SWOT Analysis 91
Table 42: Selenia S Product Profile 93
Table 43: Selenia S SWOT Analysis 93
Table 44: Selenia Performance Product Profile 95
Table 45: Selenia Performance SWOT Analysis 95
Table 46: Senographe DS Product Profile 97
Table 47: Senographe DS SWOT Analysis 97
Table 48: Senographe Essential/Senographe Essential E Product Profile 99
Table 49: Senographe Essential SWOT Analysis 99
Table 50: Senographe Care Product Profile 101
Table 51: Senographe Care SWOT Analysis 101
Table 52: SenoBright CESM Product Profile 103
Table 53: SenoBright CESM SWOT Analysis 103
Table 54: MAMMOMAT Inspiration Product Profile 105
Table 55: MAMMOMAT Inspiration SWOT Analysis 105
Table 56: Aspire HD/Amulet Product Profile 107
Table 57: Aspire HD/Amulet SWOT Analysis 107
Table 58: MammoDiagnost DR Product Profile 108
Table 59: MammoDiagnost DR SWOT Analysis 109
Table 60: MicroDose Product Profile 111
Table 61: MicroDose SWOT Analysis 111
Table 62: Giotto Image 3D/3DL Product Profile 113
Table 63: Giotto Image 3D/3DL SWOT Analysis 113
Table 64: Planmed Nuance/Nuance Excel Product Profile 115
Table 65: Planmed Nuance/Nuance Excel SWOT Analysis 115
Table 66: Fairy DR Product Profile 117
Table 67: Fairy DR SWOT Analysis 117
Table 68: Serenity Product Profile 119
Table 69: Serenity SWOT Analysis 119
Table 70: Selenia Dimensions 3D System Product Profile 121
Table 71: Selenia Dimensions SWOT Analysis 121
Table 72: GE Breast Tomosynthesis Product Profile 123
Table 73: GE Breast Tomosynthesis SWOT Analysis 123
Table 74: True 3D Breast Tomosynthesis Product Profile 125
Table 75: True 3D Breast Tomosynthesis SWOT Analysis 125
Table 76: Giotto Tomo Product Profile 127
Table 77: Giotto Tomo SWOT Analysis 127
Table 78: FUJIFILM 3Dimensional Mammography Product Profile 129
Table 79: FUJIFILM 3Dimensional Mammography SWOT Analysis 129
Table 80: somo.v ABUS Product Profile 131
Table 81: somo.v ABUS SWOT Analysis 131
Table 82: SonoCine AWBUS Product Profile 133
Table 83: SonoCine AWBUS SWOT Analysis 133
Table 84: ACUSON S2000 ABVS Product Profile 135
Table 85: Acuson S2000 ABVS SWOT Analysis 135
Table 86: Terason t3200 Ultrasound System Breast Series Product Profile 137
Table 87: Terason t3200 Ultrasound System Breast Series SWOT Analysis 137
Table 88: Aurora 1.5T Dedicated Breast MRI System Product Profile 139
Table 89: Aurora 1.5T Dedicated Breast SWOT Analysis 139
Table 90: PEM Flex Solo II Product Profile 141
Table 91: PEM Flex Solo II SWOT Analysis 141
Table 92: Computerized Tomography Laser Mammography (CTLM) Model 1020 Product Profile 143
Table 93: Computerized Tomography Laser Mammography (CTLM) Model 1020 SWOT Analysis 143
Table 94: Dilon 6800/Dilon 6800 Acella Product Profile 145
Table 95: Dilon 6800/Dilon 6800 Acella SWOT Analysis 145
Table 96: LumaGEM Product Profile 147
Table 97: LumaGEM SWOT Analysis 147
Table 98: Discovery NM 750b Product Profile 149
Table 99: Discovery NM 750b SWOT Analysis 149
Table 100: Breast Cancer Imaging Pipeline Products 163
Table 101: MAMMOMAT Inspiration PRIME Edition SWOT Analysis 164
Table 102: Philips MicroDose SI SWOT Analysis 165
Table 103: Selenia Dimensions 2D Contrast Imaging SWOT Analysis 166
Table 104: SenoCase SWOT Analysis 168
Table 105: Electrical Mammogram SWOT Analysis 169
Table 106: Other Key Events in a Breast Cancer Imaging Market 189
Table 107: GE Healthcare SWOT Analysis, 2013 193
Table 108: Hologic SWOT Analysis, 2013 195
Table 109: Siemens SWOT Analysis, 2013 196
Table 110: Koninklijke Philips Electronics SWOT Analysis, 2013 198
Table 111: Fujifilm Medical Systems, SWOT Analysis, 2013 199
Table 112: Internazionale Medico Scientifica SWOT Analysis, 2013 200
Table 113: Planmed, SWOT Analysis, 2013 201
Table 114: Konica Minolta Medical Imaging, SWOT Analysis, 2013 202
Table 115: Agfa Healthcare, SWOT Analysis, 2013 203
Table 116: Carestream Health, SWOT Analysis, 2013 204
Table 117: SonoCine, SWOT Analysis, 2013 205
Table 118: Aurora Imaging Technology, SWOT Analysis, 2013 206
Table 119: Imaging Diagnostic Systems, SWOT Analysis, 2013 208
Table 120: Naviscan, SWOT Analysis, 2013 208
Table 121: Dilon Diagnostics, SWOT Analysis, 2013 209
Table 122: Gamma Medica, SWOT Analysis, 2013 210
Table 123: Allengers Medical Systems, SWOT Analysis, 2013 211
Table 124: Major Events Affecting a APAC Breast Cancer Imaging Market, 2011- 2017 221
Table 125: Sales Forecasts for Breast Cancer Imaging in a APAC Markets, 2009–2018 221
Table 126: Sales Forecasts for Breast Cancer Imaging in Japan, 2009–2018 223
Table 127: Sales Forecasts for Breast Cancer Imaging in China, 2009–2018 224
Table 128: Sales Forecasts for Breast Cancer Imaging in India, 2009–2018 226
Table 129: Physicians Surveyed, By Country 263

List of Figures

Figure 1: Anatomy of a Breast 22
Figure 2: Breast Cancer Screening, Diagnostic Evaluation, and Follow-Up 28
Figure 3: Percentage Use of Ultrasound Imaging and MRI for Breast Cancer Screening and Follow-Up, 2009–2016 29
Figure 4: Breast Cancer Risk Factors 32
Figure 5: Breast Cancer Incidence in APAC, CAGR, 2012–2018 33
Figure 6: Projected Incidence of Breast Cancer in APAC, 2012–2018 34
Figure 7: Comparison Between Digital (FFDM) and Analog (FSM) Mammography 39
Figure 8: Use of Alternative Breast Imaging Modalities, 2009–2016 46
Figure 9: Performa 53
Figure 10: Alpha RT 55
Figure 11: Alpha ST 56
Figure 12: MAMMOMAT 1000 58
Figure 13: MAMMOMAT 3000 Nova 60
Figure 14: M-IV/M-IV Platinum 62
Figure 15: MammoDiagnost 64
Figure 16: Planmed Nuance Classic 66
Figure 17: Planmed Sophie Classic 68
Figure 18: Analog Giotto Image 70
Figure 19: HAWK-2M 72
Figure 20: MGU-1000A 74
Figure 21: Aspire CRm 77
Figure 22: KODAK DirectView CR System 78
Figure 23: Xpress CR System 80
Figure 24: REGIUS PureView Type M 82
Figure 25: DX-M Digitizer 84
Figure 26: Selenia Dimensions 87
Figure 27: Selenia 90
Figure 28: Selenia S 92
Figure 29: Selenia Performance 94
Figure 30: Senographe DS 96
Figure 31: Senographe Essential 98
Figure 32: Senographe Care 100
Figure 33: SenoBright CESM* 102
Figure 34: MAMMOMAT Inspiration 104
Figure 35: Aspire HD 106
Figure 36: MammoDiagnost DR 108
Figure 37: MicroDose 110
Figure 38: Giotto Image 3D/3DL 112
Figure 39: Planmed Nuance/Nuance Excel 114
Figure 40: Fairy DR 116
Figure 41: Serenity 118
Figure 42: Selenia Dimensions 2D System 120
Figure 43: Senographe Essential 122
Figure 44: True 3D Breast Tomosynthesis* 124
Figure 45: Giotto Tomo 126
Figure 46: Fujifilm 3D Mammography Viewer 128
Figure 47: somo.v ABUS 130
Figure 48: SonoCine AWBUS 132
Figure 49: ACUSON S2000 ABVS 134
Figure 50: Terason t3200 Ultrasound System Breast Series 136
Figure 51: Aurora 1.5T Dedicated Breast MRI System 138
Figure 52: PEM Flex Solo II 140
Figure 53: CTLM Model 1020 142
Figure 54: Dilon 6800 Acella 144
Figure 55: Dilon 6800 145
Figure 56: LumaGEM 146
Figure 57: Discovery NM 750b 148
Figure 58: Percentage of False-Positive, False-Negative and Accurate Breast Cancer Diagnoses from 2011–2012 155
Figure 59: SenoCase 167
Figure 60: Product Life Cycle 171
Figure 61: Detector Evolution 180
Figure 62: Comparison Between a Typical Direct Conversion Detector and a Direct Optical Switching Detector 182
Figure 63: Photon-Counting Detector Technology 183
Figure 64: Linear and High Transmission Cellular Grids 185
Figure 65: Sales Forecasts for Breast Cancer Imaging in APAC, 2009–2018 221
Figure 66: APAC Breast Cancer Imaging Market Revenue, by Region, 2011 and 2018 222
Figure 67: Sales Forecasts for Breast Cancer Imaging in Japan, 2009–2018 223
Figure 68: Sales Forecasts for Breast Cancer Imaging in China, 2009–2018 224
Figure 69: Sales Forecasts for Breast Cancer Imaging in India, 2009–2018 226

Companies Mentioned
GE Healthcare
Hologic
Siemens
Koninklijke Philips Electronics
Fujifilm Medical Systems
Internazionale Medico Scientifica (IMS)
Planmed
Konica Minolta Medical Imaging
Agfa Healthcare
Carestream Health
SonoCine
Aurora Imaging Technology
Imaging Diagnostic S

To sequence this report:
Medical_Imaging Industry: MediPoint: Breast Cancer Imaging – APAC Analysis and Market Forecasts

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

credit

NEW YORK, Jun 18, 2013 /PRNewswire/ — Reportlinker.com announces that a new marketplace investigate news is accessible in a catalogue:

MediPoint: Breast Cancer Imaging – Current and Future Players
http://www.reportlinker.com/p01277581/MediPoint-Breast-Cancer-Imaging—Current-and-Future-Players.html#utm_source=prnewswireutm_medium=prutm_campaign=Medical_Imaging

MediPoint: Breast Cancer Imaging – Current and Future Players

Summary

Breast cancer is a many common form of cancer in women in both a grown and building world, though is a singular illness in men. The tellurian occurrence of breast cancer is augmenting due to an augmenting lifespan and augmenting adoption of western lifestyle risk factors. Early diagnosis of breast cancer is a substructure for augmenting presence rates and evidence imaging is a many widely used technique to grasp early detection, creation evidence imaging a cornerstone of breast cancer control.

Diagnostic imaging is used for a early showing of breast cancer in asymptomatic patients in population-based screening programs in many grown countries, or for opportunistic screening in building nations. Regardless of these differences, imaging has valid to be an indispensable apparatus in fighting breast cancer and has been proven to revoke mortality.

Scope

- Investigation of stream and destiny marketplace foe for breast cancer imaging.
- Competitor assessment.
- Coverage of pivotal marketplace players and association profiles including business description, financial overview and SWOT analysis.
- Strategic comment of a breast cancer imaging shred by marketplace impact analysis, destiny marketplace unfolding and association analysis.
- Direct quotes from Key Opinion Leaders (KOLs).

Reasons to buy

- Gain a high turn perspective of a trends moulding and pushing a breast cancer imaging market.
- Assess competitiveness of products in marketplace by bargain a strengths and weaknesses of stream competition.
- Drive revenues, delineate effective sales and selling strategies and benefit in-depth bargain of a rival landscape .
- Take a extensive demeanour during a market’s device tube and brand promising, paradigm-shifting products.
- Create an effective counter-strategy to benefit a rival advantage opposite those now in a market.

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 8
1.2 List of Figures 13
2 Introduction 16
2.1 Catalyst 16
3 Competitive Assessment 17
3.1 Overview 17
3.2 Film Screen Mammography 18
3.2.1 Performa (GE Healthcare) 18
3.2.2 Alpha RT/Alpha ST (GE Healthcare) 21
3.2.3 MAMMOMAT 1000 (Siemens Healthcare) 24
3.2.4 MAMMOMAT 3000 Nova (Siemens Healthcare) 26
3.2.5 M-IV/M-IV Platinum (Hologic) 28
3.2.6 MammoDiagnost (Philips Healthcare) 30
3.2.7 Planmed Nuance Classic (Planmed) 32
3.2.8 Planmed Sophie Classic (Planmed) 34
3.2.9 Analog Giotto Image (Internazionale Medico Scientifica) 35
3.2.10 HAWK-2M (Hologic) 37
3.2.11 MGU-1000A (Toshiba Medical Systems) 39
3.3 CR Mammography 40
3.3.1 Fuji Computed Radiography Mammography Suite (FCRMS) (Fujifilm Medical Systems) 40
3.3.2 KODAK DirectView (Carestream Health) 43
3.3.3 Xpress CR System (Konica Minolta) 44
3.3.4 REGIUS PureView (Konica Minolta) 46
3.3.5 Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) (Agfa Healthcare) 47
3.4 Full-Field Digital Mammography 49
3.4.1 Selenia Dimensions (Hologic) 49
3.4.2 Selenia (Hologic) 52
3.4.3 Selenia S (Hologic) 54
3.4.4 Selenia Performance (Hologic) 55
3.4.5 Senographe DS (GE Healthcare) 57
3.4.6 Senographe Essential (GE Healthcare) 58
3.4.7 Senographe Care (GE Healthcare) 61
3.4.8 SenoBright CESM (GE Healthcare) 62
3.4.9 MAMMOMAT Inspiration (Siemens Healthcare) 64
3.4.10 Aspire HD (US)/Amulet (Outside a US) (Fujifilm) 66
3.4.11 MammoDiagnost DR (Philips Healthcare) 69
3.4.12 MicroDose (Philips Healthcare) 71
3.4.13 Giotto Image 3D/3DL (Internazionale Medico Scientifica) 73
3.4.14 Planmed Nuance/Nuance Excel (Planmed) 75
3.4.15 Fairy DR (Allengers Medical Systems) 77
3.4.16 Serenity 78
3.5 3D Mammography 79
3.5.1 Selenia Dimensions 3D System (Hologic) 79
3.5.2 GE Breast Tomosynthesis (GE Healthcare) 81
3.5.3 True 3D Breast Tomosynthesis (Siemens Healthcare) 83
3.5.4 Giotto Tomo (Internazionale Medico Scientifica) 85
3.5.5 FUJIFILM 3Dimensional Mammography (Fujifilm) 87
3.6 Breast Ultrasound Imaging 89
3.6.1 somo.v Automated Breast Ultrasound (ABUS) (GE Healthcare) 89
3.6.2 SonoCine AWBUS (SonoCine) 91
3.6.3 ACUSON S2000 ABVS (Siemens Healthcare) 92
3.6.4 Terason t3200 Ultrasound System Breast Series (Terason Ultrasound) 94
3.7 Breast MRI 95
3.7.1 Aurora 1.5T Dedicated Breast MRI System (Aurora Imaging Technology) 95
3.8 Other Breast Imaging Techniques 97
3.8.1 PEM Flex Solo II (Naviscan) 97
3.8.2 Computerized Tomography Laser Mammography (CTLM) Model 1020 (Imaging Diagnostic Systems) 99
3.8.3 Dilon 6800/Dilon 6800 Acella (Dilon Diagnostics) 101
3.8.4 LumaGEM (Gamma Medica) 103
3.8.5 Discovery NM 750b (GE Healthcare) 105
4 Pipeline Products 108
4.1 Breast Cancer Imaging Pipeline Products Overview 108
4.2 MAMMOMAT Inspiration PRIME Edition 109
4.2.1 Overview 109
4.2.2 SWOT Analysis 109
4.3 MicroDose SI 110
4.3.1 Overview 110
4.3.2 SWOT Analysis 110
4.4 Selenia Dimensions 2D Contrast-Enhanced Digital Mammography (CEDM) 111
4.4.1 Overview 111
4.4.2 SWOT Analysis 111
4.5 SenoCase 112
4.5.1 Overview 112
4.5.2 SWOT Analysis 113
4.6 Electrical Mammogram 114
4.6.1 Overview 114
4.6.2 SWOT Analysis 114
5 Current and Future Players 115
5.1 Overview 115
5.2 Trends in Corporate Strategy 116
5.3 Company Profiles 117
5.3.1 GE Healthcare 117
5.3.2 Hologic 119
5.3.3 Siemens 121
5.3.4 Koninklijke Philips Electronics 122
5.3.5 Fujifilm Medical Systems 124
5.3.6 Internazionale Medico Scientifica (IMS) 125
5.3.7 Planmed 126
5.3.8 Konica Minolta Medical Imaging 127
5.3.9 Agfa Healthcare 128
5.3.10 Carestream Health 129
5.3.11 SonoCine 130
5.3.12 Aurora Imaging Technology 131
5.3.13 Imaging Diagnostic Systems 132
5.3.14 Naviscan 133
5.3.15 Dilon Diagnostics 134
5.3.16 Gamma Medica 134
5.3.17 Allengers Medical Systems 135
6 Appendix 136
6.1 Bibliography 136
6.2 Abbreviations 154
6.3 Report Methodology 158
6.3.1 Overview 158
6.3.2 Coverage 158
6.3.3 Secondary Research 158
6.3.4 Forecast Methodology 159
6.4 Physicians and Specialists Included in this Study 160
6.5 Primary Research 161
6.6 Physician Survey 161
6.7 About a Authors 162
6.7.1 Analysts 162
6.7.2 Global Head of Healthcare 163
6.8 Definitions 164
6.9 About MediPoint 165
6.10 About GlobalData 165
6.11 Contact Us 165
6.12 Disclaimer 166

List of Tables

Table 1: Performa Product Profile 19
Table 2: Performa SWOT Analysis 20
Table 3: Alpha RT/Alpha ST Product Profile 22
Table 4: Alpha RT/Alpha ST SWOT Analysis 23
Table 5: MAMMOMAT 1000 Product Profile 24
Table 6: MAMMOMAT 1000 SWOT Analysis 25
Table 7: MAMMOMAT 3000 Nova Product Profile 27
Table 8: MAMMOMAT 3000 Nova SWOT Analysis 27
Table 9: M-IV/M-IV Platinum Product Profile 29
Table 10: M-IV/M-IV Platinum SWOT Analysis 29
Table 11: MammoDiagnost Product Profile 31
Table 12: MammoDiagnost SWOT Analysis 31
Table 13: Planmed Nuance Classic Product Profile 33
Table 14: Planmed Nuance Classic SWOT Analysis 33
Table 15: Planmed Sophie Classic Product Profile 34
Table 16: Planmed Sophie Classic SWOT Analysis 35
Table 17: Analog Giotto Image Product Profile 36
Table 18: Analog Giotto Image SWOT Analysis 36
Table 19: HAWK-2M Product Profile 38
Table 20: HAWK-2M SWOT Analysis 38
Table 21: MGU-1000A Product Profile 39
Table 22: MGU-1000A SWOT Analysis 40
Table 23: Fuji Computed Radiography Mammography Suite (FCRMS) Product Profile 42
Table 24: Fuji Computed Radiography Mammography Suite (FCRMS) SWOT Analysis 42
Table 25: KODAK DirectView CR System Product Profile 43
Table 26: KODAK DirectView CR System SWOT Analysis 44
Table 27: Xpress CR System Product Profile 45
Table 28: Xpress CR System SWOT Analysis 45
Table 29: REGIUS PureView Product Profile 46
Table 30: REGIUS PureView SWOT Analysis 47
Table 31: Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) Product Profile 48
Table 32: Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) SWOT Analysis 48
Table 33: FFDM SWOT Analysis 49
Table 34: Selenia Dimensions Product Profile 50
Table 35: Selenia Dimensions SWOT Analysis 51
Table 36: Selenia Product Profile 53
Table 37: Selenia SWOT Analysis 53
Table 38: Selenia S Product Profile 54
Table 39: Selenia S SWOT Analysis 55
Table 40: Selenia Performance Product Profile 56
Table 41: Selenia Performance SWOT Analysis 56
Table 42: Senographe DS Product Profile 57
Table 43: Senographe DS SWOT Analysis 58
Table 44: Senographe Essential/Senographe Essential E Product Profile 59
Table 45: Senographe Essential SWOT Analysis 60
Table 46: Senographe Care Product Profile 61
Table 47: Senographe Care SWOT Analysis 62
Table 48: SenoBright CESM Product Profile 63
Table 49: SenoBright CESM SWOT Analysis 64
Table 50: MAMMOMAT Inspiration Product Profile 65
Table 51: MAMMOMAT Inspiration SWOT Analysis 66
Table 52: Aspire HD/Amulet Product Profile 67
Table 53: Aspire HD/Amulet SWOT Analysis 68
Table 54: MammoDiagnost DR Product Profile 69
Table 55: MammoDiagnost DR SWOT Analysis 70
Table 56: MicroDose Product Profile 72
Table 57: MicroDose SWOT Analysis 72
Table 58: Giotto Image 3D/3DL Product Profile 74
Table 59: Giotto Image 3D/3DL SWOT Analysis 74
Table 60: Planmed Nuance/Nuance Excel Product Profile 76
Table 61: Planmed Nuance/Nuance Excel SWOT Analysis 76
Table 62: Fairy DR Product Profile 77
Table 63: Fairy DR SWOT Analysis 78
Table 64: Serenity Product Profile 79
Table 65: Serenity SWOT Analysis 79
Table 66: Selenia Dimensions 3D System Product Profile 80
Table 67: Selenia Dimensions SWOT Analysis 81
Table 68: GE Breast Tomosynthesis Product Profile 82
Table 69: GE Breast Tomosynthesis SWOT Analysis 83
Table 70: True 3D Breast Tomosynthesis Product Profile 84
Table 71: True 3D Breast Tomosynthesis SWOT Analysis 85
Table 72: Giotto Tomo Product Profile 86
Table 73: Giotto Tomo SWOT Analysis 87
Table 74: FUJIFILM 3Dimensional Mammography Product Profile 88
Table 75: FUJIFILM 3Dimensional Mammography SWOT Analysis 88
Table 76: somo.v ABUS Product Profile 90
Table 77: somo.v ABUS SWOT Analysis 90
Table 78: SonoCine AWBUS Product Profile 91
Table 79: SonoCine AWBUS SWOT Analysis 92
Table 80: ACUSON S2000 ABVS Product Profile 93
Table 81: Acuson S2000 ABVS SWOT Analysis 94
Table 82: Terason t3200 Ultrasound System Breast Series Product Profile 95
Table 83: Terason t3200 Ultrasound System Breast Series SWOT Analysis 95
Table 84: Aurora 1.5T Dedicated Breast MRI System Product Profile 96
Table 85: Aurora 1.5T Dedicated Breast SWOT Analysis 97
Table 86: PEM Flex Solo II Product Profile 98
Table 87: PEM Flex Solo II SWOT Analysis 99
Table 88: Computerized Tomography Laser Mammography (CTLM) Model 1020 Product Profile 100
Table 89: Computerized Tomography Laser Mammography (CTLM) Model 1020 SWOT Analysis 101
Table 94: Dilon 6800/Dilon 6800 Acella Product Profile 103
Table 95: Dilon 6800/Dilon 6800 Acella SWOT Analysis 103
Table 92: LumaGEM Product Profile 104
Table 93: LumaGEM SWOT Analysis 105
Table 94: Discovery NM 750b Product Profile 106
Table 95: Discovery NM 750b SWOT Analysis 107
Table 96: Breast Cancer Imaging Pipeline Products 108
Table 97: MAMMOMAT Inspiration PRIME Edition SWOT Analysis 109
Table 98: Philips MicroDose SI SWOT Analysis 110
Table 99: Selenia Dimensions 2D Contrast Imaging SWOT Analysis 111
Table 100: SenoCase SWOT Analysis 113
Table 101: Electrical Mammogram SWOT Analysis 114
Table 102: GE Healthcare SWOT Analysis, 2013 119
Table 103: Hologic SWOT Analysis, 2013 121
Table 104: Siemens SWOT Analysis, 2013 122
Table 105: Koninklijke Philips Electronics SWOT Analysis, 2013 123
Table 106: Fujifilm Medical Systems, SWOT Analysis, 2013 124
Table 107: Internazionale Medico Scientifica SWOT Analysis, 2013 125
Table 108: Planmed, SWOT Analysis, 2013 126
Table 109: Konica Minolta Medical Imaging, SWOT Analysis, 2013 127
Table 110: Agfa Healthcare, SWOT Analysis, 2013 128
Table 111: Carestream Health, SWOT Analysis, 2013 129
Table 112: SonoCine, SWOT Analysis, 2013 130
Table 113: Aurora Imaging Technology, SWOT Analysis, 2013 131
Table 114: Imaging Diagnostic Systems, SWOT Analysis, 2013 133
Table 115: Naviscan, SWOT Analysis, 2013 133
Table 116: Dilon Diagnostics, SWOT Analysis, 2013 134
Table 117: Gamma Medica, SWOT Analysis, 2013 135
Table 118: Allengers Medical Systems, SWOT Analysis, 2013 135
Table 119: Physicians Surveyed, By Country 161

List of Figures

Figure 1: Performa 18
Figure 2: Alpha RT 20
Figure 3: Alpha ST 21
Figure 4: MAMMOMAT 1000 23
Figure 5: MAMMOMAT 3000 Nova 25
Figure 6: M-IV/M-IV Platinum 27
Figure 7: MammoDiagnost 29
Figure 8: Planmed Nuance Classic 31
Figure 9: Planmed Sophie Classic 33
Figure 10: Analog Giotto Image 34
Figure 11: HAWK-2M 36
Figure 12: MGU-1000A 38
Figure 13: Aspire CRm 40
Figure 14: KODAK DirectView CR System 42
Figure 15: Xpress CR System 43
Figure 16: REGIUS PureView Type M 45
Figure 17: DX-M Digitizer 46
Figure 18: Selenia Dimensions 49
Figure 19: Selenia 51
Figure 20: Selenia S 53
Figure 21: Selenia Performance 54
Figure 22: Senographe DS 56
Figure 23: Senographe Essential 58
Figure 24: Senographe Care 60
Figure 25: SenoBright CESM* 62
Figure 26: MAMMOMAT Inspiration 64
Figure 27: Aspire HD 66
Figure 28: MammoDiagnost DR 68
Figure 29: MicroDose 70
Figure 30: Giotto Image 3D/3DL 72
Figure 31: Planmed Nuance/Nuance Excel 74
Figure 32: Fairy DR 76
Figure 33: Serenity 77
Figure 34: Selenia Dimensions 2D System 79
Figure 35: Senographe Essential 81
Figure 36: True 3D Breast Tomosynthesis* 83
Figure 37: Giotto Tomo 85
Figure 38: Fujifilm 3D Mammography Viewer 87
Figure 39: somo.v ABUS 88
Figure 40: SonoCine AWBUS 90
Figure 41: ACUSON S2000 ABVS 92
Figure 42: Terason t3200 Ultrasound System Breast Series 93
Figure 43: Aurora 1.5T Dedicated Breast MRI System 95
Figure 44: PEM Flex Solo II 97
Figure 45: CTLM Model 1020 99
Figure 46: Dilon 6800 Acella 101
Figure 47: Dilon 6800 101
Figure 48: LumaGEM 103
Figure 49: Discovery NM 750b 105
Figure 50: SenoCase 111

To sequence this report:
Medical_Imaging Industry: MediPoint: Breast Cancer Imaging – Current and Future Players

Contact Clare: clare@reportlinker.com  
US:(339) 368 6001
Intl:+1 339 368 6001

credit

Health Briefs
The Kaiser Permanente Fontana Medical Center has received international recognition as a baby-friendly hospital, by Baby-Friendly USA, a program sponsored by the World Health Organization and the United Nations Children s Fund.

Read more on Inland Valley Daily Bulletin

credit

“I adore a organisation spirit, we only adore all about it. It is like a floating support organisation on a water,” pronounced Lydia Collins, who assimilated 5 years ago after being diagnosed with breast cancer.

Dragon boating is a organisation sport  that goes behind some-more than 2,000 years. The vessel is ornate with a dragon conduct and tail before races. In new years, a flourishing series of breast cancer survivor groups around a universe have started to use a competition to reconstruct their lives and forge friendships.

credit

“Many investigators had assumed that once breast cancer cells developed resistance to tamoxifen, they would be resistant to all drugs that target the estrogen receptor,” says Donald McDonnell, chair of Duke’s Department of Pharmacology and Cancer Biology. “We discovered that the estrogen receptor is still a good target, even after it resistance to tamoxifen has developed.”

Like tamoxifen, bazedoxifene targets estrogen receptors, with the ability to mimic estrogen in some tissue while blocking estrogen in other tissue. In bone tissue, bazedoxifene was found to imitate estrogen action, helping to protect the tissue from destruction.

Bazedoxifene is approved in Europe for use in treating osteoporosis. The drug has already undergone safety and efficacy testing, and may be an option in the near future for patients with advanced breast cancer. In the clinical trials, hot flashes were the most often reported side effect.